{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:04:46Z","timestamp":1772759086068,"version":"3.50.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>The coronavirus disease (COVID-19), a worldwide pandemic, is caused by the severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2). At this moment in time, there are no specific therapeutics available to combat COVID-19. Drug repurposing and identification of naturally available bioactive molecules to target SARS-CoV-2 are among the key strategies to tackle the notorious virus. The enzyme RNA-dependent RNA polymerase (RdRp) performs a pivotal role in replicating the virus. RdRp is a prime target for Remdesivir and other nucleotides analog-based antiviral drugs. In this study, we showed three bioactive molecules from tea (epicatechin-3,5-di-O-gallate, epigallocatechin-3,5-di-O-gallate, and epigallocatechin-3,4-di-O-gallate) that showed better interaction with critical residues present at the catalytic center and the NTP entry channel of RdRp than antiviral drugs Remdesivir and Favipiravir. Our computational approach to identify these molecules included molecular docking studies, followed by robust molecular dynamics simulations. All the three molecules are readily available in tea and could be made accessible along with other medications to treat COVID-19 patients. However, these results require validation by further<jats:italic>in vitro<\/jats:italic>and<jats:italic>in vivo<\/jats:italic>studies.<\/jats:p>","DOI":"10.3389\/fmed.2021.684020","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T05:13:40Z","timestamp":1622438020000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Bioactive Molecules of Tea as Potential Inhibitors for RNA-Dependent RNA Polymerase of SARS-CoV-2"],"prefix":"10.3389","volume":"8","author":[{"given":"Vijay Kumar","family":"Bhardwaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatin","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidya","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rituraj","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J Biol Chem."},{"key":"B2","volume-title":"COVID-19 Situation Report 29","year":"2020"},{"key":"B3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"104793","DOI":"10.1016\/j.antiviral.2020.104793","article-title":"Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 exonuclease active-sites","volume":"178","author":"Shannon","year":"2020","journal-title":"Antiviral Res."},{"key":"B5","unstructured":"COVID-19 treatment by repurposing drugs until the vaccine is in sight5413 PhadkeM SaunikS 10.1002\/ddr.2166632227357Drug Dev Res.812020"},{"key":"B6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in saudi arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1038\/s41467-019-10280-3","article-title":"Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors","volume":"10","author":"Kirchdoerfer","year":"2019","journal-title":"Nat Commun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet."},{"key":"B12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science."},{"key":"B13","doi-asserted-by":"publisher","first-page":"E3900","DOI":"10.1073\/pnas.1323705111","article-title":"One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities","volume":"111","author":"Subissi","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"B14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/wrna.1164","article-title":"RNA synthetic mechanisms employed by diverse families of RNA viruses","volume":"4","author":"Mcdonald","year":"2013","journal-title":"Wiley Interdiscip Rev RNA."},{"key":"B15","doi-asserted-by":"publisher","first-page":"8416","DOI":"10.1093\/nar\/gkv838","article-title":"Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerase-containing protein of all nidoviruses","volume":"43","author":"Lehmann","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"22505","DOI":"10.1073\/pnas.1007626107","article-title":"Structural basis for active site closure by the poliovirus RNA-dependent RNA polymerase","volume":"107","author":"Gong","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e1006889","DOI":"10.1371\/journal.ppat.1006889","article-title":"Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase","volume":"14","author":"Jordan","year":"2018","journal-title":"PLoS Pathog."},{"key":"B20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3390\/v11040326","article-title":"Mechanism of inhibition of ebola virus RNA-dependent RNA polymerase by remdesivir","volume":"11","author":"Tchesnokov","year":"2019","journal-title":"Viruses."},{"key":"B21","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.2174\/1381612811319340008","article-title":"Tea and health: studies in humans","volume":"19","author":"Khan","year":"2013","journal-title":"Curr Pharm Des."},{"key":"B22","doi-asserted-by":"publisher","first-page":"128932","DOI":"10.1016\/j.foodchem.2020.128932","article-title":"Himalayan bioactive molecules as potential entry inhibitors for the human immunodeficiency virus","volume":"347","author":"Kumar Bhardwaj","year":"2021","journal-title":"Food Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/molecules22081337","article-title":"A review of the antiviral role of green tea catechins","volume":"22","author":"Xu","year":"2017","journal-title":"Molecules."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1766572","article-title":"Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors","author":"Bhardwaj","year":"2020","journal-title":"J Biomol Struct Dyn."},{"key":"B25","doi-asserted-by":"publisher","first-page":"128933","DOI":"10.1016\/j.foodchem.2020.128933","article-title":"An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2","volume":"346","author":"Sharma","year":"2020","journal-title":"Food Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijbiomac.2021.02.012","article-title":"Epigallocatechin-3-gallate, an active ingredient of traditional Chinese medicines, inhibits the 3CLpro activity of SARS-CoV-2","volume":"176","author":"Du","year":"2021","journal-title":"Int J Biol Macromol."},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1101\/2020.12.04.412098","article-title":"Significant inactivation of SARS-CoV-2 by a green tea catechin, a catechin-derivative and galloylated theaflavins in vitro","volume-title":"bioRxiv [Preprint].","author":"Ohgitani","year":"2020"},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-021-00680-8","article-title":"Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor","volume-title":"bioRxiv [Preprint].","author":"Liu","year":"2021"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Science."},{"key":"B30","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/jcc.540040211","article-title":"CHARMM: a program for macromolecular energy, minimization, and dynamics calculations","volume":"4","author":"Brooks","year":"1983","journal-title":"J Comput Chem."},{"key":"B32","first-page":"98","article-title":"Dassault systemes BIOVIA, discovery studio modelling environment, release 4.5","author":"Studio","year":"2015","journal-title":"Accelrys Softw Inc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1021\/acs.jctc.7b00719","article-title":"Efficient geometry minimization and transition structure optimization using interpolated potential energy surfaces and iteratively updated hessians","volume":"13","author":"Zheng","year":"2017","journal-title":"J Chem Theory Comput."},{"key":"B34","unstructured":"AbrahamMJ van der SpoelD LindahlE HessB ApolE BerendsenHJC GROMACS User Manual version 5.0.52015"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J Comput Chem."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"G-mmpbsa -A GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J Chem Inf Model."},{"key":"B38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jnutbio.2012.12.013","article-title":"Modulation of adipose tissue inflammation by bioactive food compounds","volume":"24","author":"Siriwardhana","year":"2013","journal-title":"J Nutr Biochem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1074\/jbc.M110.183780","article-title":"Development of defective and persistent Sendai virus vector: a unique gene delivery\/expression system ideal for cell reprogramming","volume":"286","author":"Nishimura","year":"2011","journal-title":"J Biol Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-020-2368-8","article-title":"Structure of replicating SARS-CoV-2 polymerase","volume":"584","author":"Hillen","year":"2020","journal-title":"Nature."},{"key":"B41","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nsb0902-646","article-title":"Molecular dynamics simulations of biomolecules","volume":"9","author":"Karplus","year":"2002","journal-title":"Nat Struct Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0959-440X(02)00308-1","article-title":"Molecular dynamics simulations","volume":"12","author":"Hansson","year":"2002","journal-title":"Curr Opin Struct Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1073\/pnas.0408930102","article-title":"Molecular dynamics and protein function","volume":"102","author":"Karplus","year":"2005","journal-title":"Proc Natl Acad Sci USA."},{"key":"B44","doi-asserted-by":"publisher","first-page":"104117","DOI":"10.1016\/j.compbiomed.2020.104117","article-title":"Evaluation of acridinedione analogs as potential SARS-CoV-2 main protease inhibitors and their comparison with repurposed anti-viral drugs","volume":"128","author":"Bhardwaj","year":"2021","journal-title":"Comput Biol Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.ijbiomac.2020.09.098","article-title":"Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach","volume":"163","author":"Parvez","year":"2020","journal-title":"Int J Biol Macromol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ijbiomac.2020.01.212","article-title":"A new insight into protein-protein interactions and the effect of conformational alterations in PCNA","volume":"148","author":"Bhardwaj","year":"2020","journal-title":"Int J Biol Macromol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fmolb.2015.00005","article-title":"On the energy components governing molecular recognition in the framework of continuum approaches","volume":"2","author":"Li","year":"2015","journal-title":"Front Mol Biosci."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.684020\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T03:28:57Z","timestamp":1672284537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.684020\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,31]]},"references-count":47,"alternative-id":["10.3389\/fmed.2021.684020"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.684020","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,31]]},"article-number":"684020"}}